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ABSTRACT
Objective: Chronic Helicobacter pylori (H. pylori) infection promotes non-cardia 
gastric cancer. Some mouse models suggest that bone marrow derived cells (BMDC) 
contribute to Helicobacter-associated gastric carcinogenesis. We determined whether 
this increased susceptibility to Helicobacter-induced gastric carcinogenesis of p27-
deficient mice is dependent upon their p27-null BMDC or their p27-null gastric 
epithelial cells. 
Design: Female mice (recipients) were irradiated and transplanted with BMDC 
from male donors. Wild type (WT) mice in group 1 (control) received BMDC from male 
GFP-transgenic mice. Female WT and p27 KO mice were engrafted with male p27KO 
mice BMDC (Group 2) or GFP-transgenic WT BMDC (Group 3). Recipients were infected 
with H. pylori SS1 for one year. 
Results: Mice lacking p27 in either the BM pool or gastric epithelium 
developed significantly more advanced gastric pathology, including high-grade 
dysplasia. Co-staining of donor BMDC in dysplastic gastric glands was confirmed by 
immunofluorescence. Gastric expression of IL-1 beta protein was reduced in groups 2 
and 3 (p < 0.05 vs control) whereas expression of IFN-γ and chemokines MIP-1 beta, 
MIG, IP-10 and RANTES in group 2 were significantly higher than group 3. 
Conclusions: Both bone marrow-derived and gastric epithelial cells contribute 
to the increased gastric cancer susceptibility of p27-deficient H. pylori-infected mice.
INTRODUCTION
Gastric cancer is the fifth most common neoplasm 
and the third leading cause of cancer death worldwide. [1] 
Most cases of gastric cancer are attributable to persistent 
chronic infection by Helicobacter pylori (H. pylori), 
including almost 90% of cases of non-cardia gastric 
cancer. [2] Since H. pylori was designated a definite gastric 
carcinogen in 1994, [3] the pathogenesis of H. pylori 
infection has been extensively studied, but exactly how 
this bacterium and/or the associated gastric inflammatory 
response contributes to gastric carcinogenesis remains 
poorly defined. 
Gastric malignancy usually develops after a multi-
step, decades-long process, as proposed by Correa in 
1975. [4] In this “conventional model”, the epithelial cells 
and glands of the gastric mucosa undergo progressive 
histological change, as confirmed by numerous murine 
studies. [5-7] Additional steps to this model were 
proposed by Houghton et al in 2004, [8] based upon H. 
felis infection in wild type C57BL/6 mice. In that model, 
chronic Helicobacter infection triggered the migration 
of bone marrow-derived cells (BMDC) to the stomach, 
where they gave rise to neoplastic gastric epithelial cells 
and progressed to gastric adenocarcinoma via the classic 
changes described by Dr. Correa. [8] H. pylori infection 
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in mice induces less severe gastric mucosal alteration, 
and rarely if ever causes adenocarcinoma. Nevertheless, 
support for the “BMDC model” has come from similar 
experiments by Varon and colleagues using mice infected 
by H. pylori Sydney Strain 1 (SS1), [9] in which BMDC 
were identified in approximately 25% of dysplastic gastric 
lesions, which are thought to be precursors of gastric 
adenocarcinoma.
Since wild type C57BL/6 mice rarely develop 
gastric cancer, even after 80 weeks H. pylori infection, 
[10] our goal was to evaluate the contribution of BMDC 
to gastric cancer in a mouse model that is susceptible to H. 
pylori-induced gastric carcinogenesis. [11] For the current 
study, we chose p27Kip1 deficient (p27 KO) mice, since 
our laboratory has shown that these mice develop gastric 
cancer about a year after H. pylori SS1 infection, after 
slowly progressing through a sequence of pathological 
changes, recapitulating human H. pylori-associated gastric 
carcinogenesis. [12] 
We used the p27-deficient gastric cancer prone 
model to evaluate the relative contributions of BMDC 
to epithelial cells in H. pylori-induced gastric cancer. 
BMDC are critical for the development of dysplasia 
and neoplasia in the Helicobacter models, however, the 
relative contribution of genetic defects in the epithelial 
and BM cell compartments have not been studied. We 
hypothesized that if BMDC were critical for H. pylori-
induced gastric carcinogenesis in p27-deficient mice, then 
the p27-deficient bone marrow-derived, rather than the 
p27-deficient gastric epithelial cells would be responsible 
for gastric tumorigenesis following H. pylori infection. 
To determine whether the loss of p27 expression in bone 
marrow-derived cells (in a background of wild type 
epithelium) or loss of p27 expression in gastric epithelial 
cells (with wild type BM cells) contributes to in H. pylori-
infected gastric mucosa, we generated chimeric mice by 
transplantation of BM via lateral tail vein injection of 
p27 knock-out or wild type BMDC into wild type and 
p27-deficient recipients, respectively, using wild type to 
wild type autologous mice to control for the effects of 
radiation and bone marrow transplantation. After bone 
marrow transplantation and long term H. pylori infection, 
we evaluated cell lineages in the context of gastric 
pathological changes to address the cellular origins of H. 
pylori-associated gastric carcinoma. 
RESULTS
There were three groups of mice in the present 
study, all on a C57BL/6 background, as shown in Table 1. 
All donors were males and recipients were females. 
Successful bone marrow transplantation
For the mice that recovered from sublethal 
irradiation, bone marrow transplantation was evaluated 
52 weeks after H. pylori infection as shown in Figure 1. 
Since the bone marrow donor mice in experimental groups 
1 and 3 expressed enhanced green fluorescent protein 
(GFP), immunofluorescence staining was performed to 
detect these bone marrow-derived cells (stained green) in 
the stomachs of recipient mice (Figure 1A). In the mice 
in experimental group 2, the presence of donor bone 
marrow-derived cells in the stomachs of the recipients 
was instead confirmed by staining Y-chromosomes from 
the male donors by FISH. Donor derived Y-chromosomes 
were labeled with a Cy3-conjugated probe (red), located 
within the DAPI stained nucleus (blue) in merged image 
(Figure 1B). The presence of bone marrow-derived GFP-
positive cells (group 3) or Y-chromosome stained cells 
(group 2) could be frequently detected in the dysplastic 
gastric glands in these two experimental groups of mice 
(Figure 1). 
Table 1: Experimental Design
Donors Recipients
Group 1
(Control)
♂ Wild Type
(GFP-expressing)
♀ Wild Type
Group 2 ♂ p27 -/- Mice ♀ Wild Type
Group 3 ♂ Wild Type
(GFP-expressing) ♀ p27-/- Mice
Donor and recipient mice in three experimental groups. In this study, all of the mice have 
C57BL/6 background and all donors are males, recipients are females. ♂ : Male, ♀ : Female, 
GFP: Green Fluorescent Protein. 
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Histological evaluation
Mice were euthanized 52 weeks after H. pylori 
infection by gavage (all groups), and the gastric histology 
was evaluated by hematoxylin and eosin (H&E) staining. 
Representative H&E stained histological images from 
the three groups at 52 weeks post infection are shown 
in Figure 2, with higher magnification images in the left 
lower corner of each panel. In the control group (Group 1), 
all the mice survived until the end of the study. Although 
our aim was to determine the origin of gastric cancer cells, 
we did notice differences in survival curves during the 
study. In Kaplan-Meier analysis, group 3 p27 KO mice 
which received wild type bone marrow had significantly 
poorer overall survival compared with group 1 control 
Figure 1: Determination of Bone Marrow-derived GFP-expressing Cells And Male Donor-derived Y-chromosome 
in Recipient Mice infected by H. pylori. A. Immunofluorescence staining detected marrow-derived cells, which were stained green 
in group 1 and group 3. Nuclei labeled blue by DAPI in left panels. B. In group 2, Y-chromosomes from male donor mice were detected 
by performing Fluorescence in situ hybridization (FISH). Donor derived Y-chromosomes were labeled with Cy3-conjugated probe (red), 
which were located within the DAPI stained nucleus (blue) in merged images. Many of the donor cells were incorporated in gastric glands.
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mice and group 2 wild type mice which received p27 KO 
marrow cells (data not shown). The cause of premature 
death in our group 3 mice was likely from multiple 
endocrine and/or hematological tumors rather than their 
stomach pathology. [13-15] 
Although group 1 mice have intensive gastric 
inflammatory cell infiltration, they retained normal 
gastric epithelial architecture, and only developed 
mild hyperplasia and pseudopyloric metaplasia (higher 
magnification image), but no dysplasia. In contrast, mice 
in groups 2 and 3 exhibited more complex gastric mucosal 
architecture with dysplastic features including atypical and 
heterogeneous gastric glands, coupled with variability in 
epithelial cell size and enlarged and hyperchromatic nuclei 
(see higher magnification image). These histopathological 
findings were quantified for each animal (Figure 3) by 
scoring inflammation, epithelial defects, oxyntic atrophy, 
hyperplasia, pyloric metaplasia, and dysplasia separately 
on a scale of 0 – 4 and comparing differences among 
groups (Figure 3A). [11] The total Histologic Activity 
Index (Figure 3B), a combination of the above individual 
criteria scores, was also calculated. In general, wild type 
(WT) mice in the control group showed a milder gastric 
phenotype for all parameters, whereas mice in groups 2 
and 3 developed statistically significantly more severe 
lesions across criteria. The statistical analysis showed 
no significant differences among the scores for group 2 
and group 3 mice. None of the mice developed invasive 
cancer.
Bone marrow-derived cells express E-cadherin 
and incorporate into gastric glands
Cadherins are important calcium-dependent cell 
transmembrane adhesion proteins present on gastric 
epithelial cells; downregulation of E-cadherin has been 
implicated in tumorigenesis. [16] As group 2 mice 
received BMDC from p27 deficient mice, no GFP-
expressing cells were detectable. To detect whether bone 
marrow-derived cells in mice express E-cadherin and 
incorporate into gastric glands, we performed triple-
color staining in each group. We conducted E-Cadherin 
(red) immunofluorescence staining and combined it 
with either Y-Chromosome FISH in groups 1 and 2, or 
immunofluorescence staining for GFP (green) in groups 
1 and 3. Subsequently, nuclei were stained with DAPI 
(blue) to provide composite images (Figure 4A and 4B). 
The staining clearly showed male donor-derived BMDC 
incorporated into gastric glands. Gastric epithelial cells 
were marked with E-Cadherin. Bright, intact E-Cadherin 
staining was seen in the control group whereas there was 
much weaker and discontinuous E-Cadherin expression in 
dysplastic areas in group 2 and 3 mice. Y-chromosome 
positive or GFP-expressing donor mouse derived BMDCs 
were abundant in H. pylori-infected gastric mucosa and in 
the dysplastic gastric glands of group 2 and 3, while only 
very few BMDCs in group 1 (control) were detected. In 
group 3 mice, there were areas of numerous GFP-positive 
cells in some irregular dysplastic glands, with very few 
non-donor-derived cells. And within the glands, these 
donor cells also expressed E-cadherin (Figure 4A and 4B).
In comparison with control mice, donor-derived 
Y-chromosome positive cells were more frequent in 
group 2 mice (Figure 4C, left panel, 17 ± 1 vs 68 ± 16 
per high power field, *P < 0.05). More GFP-expressing 
BMDCs were engrafted in the inflamed gastric mucosa 
and incorporated into the gastric glands, especially in 
dysplastic glands, in group 3 mice compared with the 
control (group 1 mice) (Figure 4C, right panel, 15 ± 2 
vs 62 ± 14 per high power field, *P < 0.05). Data were 
expressed as mean ± standard error of the mean (SEM).
Figure 2: Representative Gastric Histopathology in Recipient Mice. Representative histopathology from the three groups of 
mice at 52 weeks post H. pylori infection (Hematoxylin and eosin staining). Mice in the control group (Group 1) developed mild gastric 
epithelial hyperplasia and mild pseudopyloric metaplasia but, unlike the mice in groups 2 and 3, there was no progression to dysplasia. In 
contrast there was evidence of more advanced gastric pathological abnormality in mice in groups 2 and 3. Original magnification x 100, 
higher power (insets) x 200.
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Expression of proinflammatory cytokines and 
chemokines in gastric mucosa
To evaluate the nature of the inflammatory 
milieu we assessed the gastric mucosal levels of three 
proinflammatory cytokines and six chemokines using 
a customized multiplexed protein quantification assay, 
according to the manufacturer’s instructions (EMD 
Millipore, MA, USA). Data were expressed as mean ± 
SEM. There were no significant differences in protein 
levels of MCP-1 and MIP-1 α among the three groups. 
However, in comparison with controls, TNF-α levels were 
reduced in group 3 (5.75 ± 0.85 pg/mg protein, P < 0.05 vs 
control 12.61 ± 1.93 pg/mg protein), and there was lower 
IL-1β expression in groups 2 and 3 (23.45 ± 3.48 pg/mg 
protein; 23.75 ± 3.18 pg/mg protein, respectively, P < 0.05 
vs control 44.37 ± 5.23 pg/mg protein). When compared 
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Figure 3: Gastric Histology Scores in H. pylori-infected Recipient Mice. A. The Individual gastric lesion scores of every mouse in 
each group, including inflammation, epithelial defects, oxyntic atrophy, hyperplasia, pyloric metaplasia, and dysplasia, were graded on a 
scale of 0 - 4. B. Total Histological Activity Index is a combination of all the six individual criteria scores (scored from 0 - 24). In general, 
wild type mice in the control group showed a milder gastric pathology, while the two other groups developed advanced pathological lesions. 
Each empty circle, triangle and square represents one mouse in each group, respectively. The bar represents the median score in each group. 
N = 5, 37, 18 in groups 1, 2, 3, respectively. *P < 0.05, **P < 0.01 vs group 1 (control). There was no statistically significant difference 
between group 2 and group 3 mice.
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Figure 4: Bone Marrow-Derived Cells (BMDCs) Incorporated into Gastric Glands. A. Y-Chromosome detection by FISH 
(green) was combined with E-Cadherin (red) immunofluorescence staining, then merged with DAPI (blue) in groups 1, 2. Bar: 20 μm. B. 
GFP (green) and E-Cadherin (red) immunofluorescence staining were merged with DAPI (blue) in groups 1 and 3. These images clearly 
showed that BMDCs incorporated into gastric glands. BMDCs were frequently observed in dysplastic gastric glands in group 2 and 3. C. 
Left panel: Quantification of Y-Chromosome positive BMDCs incorporated into gastric glands per high power field. *P < 0.05. Right panel: 
Quantification of GFP positive BMDCs incorporated into gastric glands per high power field. *P < 0.05. GFP: Green Fluorescent Protein.
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with group 3 mice, IFN-γ (43.62 ± 9.36 pg/mg protein) 
and MIP-1 β expression (42.39 ± 6.19 pg/mg protein) 
in group 2 were markedly elevated (P < 0.05 vs 16.91 ± 
2.27 pg/mg protein; 24.83 ± 2.26 pg/mg protein in group 
3, respectively). In addition, IP-10, RANTES and MIG 
levels were significantly increased in group 2 (64.38 ± 
9.94; 81.79 ±15.82; 286.1 ± 75.39 pg/mg protein, when 
compared with group 3 (20.84 ± 4.1; 23.21 ± 6.79; 55.31 
± 29.4 pg/mg protein, respectively, P < 0.05 vs group 
3 for each comparison). N = 5, 22, 18 in groups 1, 2, 3, 
respectively (Figure 5).
DISCUSSION
Chronic H. pylori infection is a major risk factor for 
the development of distal gastric carcinoma. [17] Despite 
decades of research in this field, how H. pylori and its 
associated gastric inflammatory response promote gastric 
neoplasia remains unclear. Studies in mouse models 
using H. felis, a murine-adapted Helicobacter, supports 
the notion that the cancer stem cell in gastric cancer 
originates from bone marrow-derived cells drawn to an 
inflamed gastric milieu by chronic bacterial colonization. 
Figure 5: Expression of Proinflammatory Cytokines and Chemokines in Gastric Mucosa. Protein levels of specific 
proinflammatory cytokines and chemokines in mice stomach tissue were analyzed in a multiplex assay. There were no significant differences 
in protein levels of MCP-1 and MIP-1 α among the three groups, while IFN-γ, MIP-1 β, IP-10, RANTES and MIG levels were significantly 
elevated in group 2 when compared with group 3. TNF-α levels in group 3, and IL-1β expression in group 2 and group 3 were significantly 
lower than those protein levels in control group, respectively. Data were expressed as mean ± SEM (pg/mg protein). SEM: the standard 
error of the mean. N = 5, 22, 18 in groups 1, 2, 3, respectively. *P < 0.05, **P < 0.01 vs control.
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[8, 9] Similar findings have been reported using H. pylori, 
lending more human relevance to the findings. However, 
H. pylori infection in the mouse model progresses to 
dysplasia and not to frank carcinoma. Therefore, it remains 
uncertain whether gastric epithelial cells or bone marrow-
derived stem cells initiate gastric cancer development in 
the H. pylori-infected mouse model. 
In the present study, we utilized cancer-prone 
p27-deficient mice that develop gastric cancer about 
one year after experimental H. pylori infection [12] to 
explore whether their increased cancer susceptibility 
was due to p27 deficiency in their bone marrow-derived 
cells or in their gastric epithelial cells. Wild type mice 
receiving autologous bone marrow followed by H. pylori 
infection served as an experimental control to evaluate 
the effects of radiation, bone marrow transplantation, 
and to compare with the other two groups in terms of 
pathological changes and cytokine expression. Using GFP 
and Y-chromosome markers to track bone marrow-derived 
cells, we observed that very few GFP+ bone marrow-
derived cells were incorporated into the normal gastric 
glands of the control mice whereas many cells derived 
from the bone marrow appeared to be incorporated into the 
dysplastic gastric glands of mice deficient in p27. Image 
quantification analysis further confirmed that compared 
with group 1 control mice, there was a higher frequency of 
Y-chromosome positive or GFP-expressing donor mouse 
derived BMDCs incorporated into the recipient’s gastric 
glands, especially within the dysplastic areas of group 
2 and 3 mice. These results indicate that the irradiation 
protocol does not cause significant structural damage in 
gastric mucosa, and that engrafted bone marrow cells 
participate in the development of gastric dysplasia related 
to H. pylori stimulation. These results therefore support 
previous findings in different Helicobacter-infected mouse 
models. [8, 9]
Since our previous reports demonstrated that H. 
pylori-infected p27-deficient mice are susceptible to 
advanced gastric preneoplastic and neoplastic lesions, [12, 
18] we predicted that if gastric cancer originated in bone 
marrow-derived cells, then wild type mice that received 
p27-deficent bone marrow cells (group 2) should have the 
highest cancer incidence of the three experimental mouse 
groups. However, our results indicated that the increased 
susceptibility of these mice to H. pylori-induced gastric 
pathology was equal to that of the mice in group 3 that 
lacked p27 in all cells except the bone marrow. 
Group 2 mice, which received p27-deficient bone 
marrow, showed  significantly higher inflammation scores 
compared with control mice. Although p27 deficiency 
does not increase the number of stem cells in the bone 
marrow, mice lacking p27 have increased cytokine-
stimulated T cell proliferation in the peripheral lymphoid 
organs, [19-21] which may lead to increased cytokine 
secretion and enhanced inflammatory responses in the 
stomachs of the wild type H. pylori-infected mice that 
received p27-deficient bone marrow cells. Mice in group 3 
that lacked p27 in all cells except their bone marrow cells 
also displayed increased inflammation compared with 
autologous wild type controls, though the difference was 
not statistically significant, probably because of a small 
sample size in the controls. Nevertheless, this indicates 
that gastric epithelial cell p27 may normally play a role 
in down-regulating inflammatory and pro-neoplastic 
responses to H. pylori. 
Cytokines and chemokines are important mediators 
that mediate and coordinate host immune responses 
to pathogen infection and invasion. Previous studies 
have demonstrated that H. pylori infection induces the 
expression of multiple inflammatory cytokines and 
chemokines. [22-24] We investigated the nature of 
gastric inflammatory during chronic H. pylori infection 
in all groups of mice in our study through sampling the 
expression of several proinflammatory cytokines (IFN-γ, 
TNF-α and IL-1β) and chemotactic chemokines (MCP-1, 
MIP-1α, MIP-1β, IP-10, RANTES and MIG) by a protein 
multiplex array. At 52 weeks after H. pylori infection, 
there was very low expression of the T helper 1 cytokine 
TNF-α, and no significant differences in MCP-1 and MIP-
1α among the three groups. Unexpectedly, in contrast to 
other studies, IL-1β expression in groups 2 and 3 that 
developed gastric dysplasia was significantly lower than 
that of control group. [25, 26]
Interestingly, although the severity of mucosal 
lesions and the degree of inflammation assessed by 
standard pathological criteria were similar in group 2 and 
group 3 mice, they displayed quite different cytokine/
chemokine protein expression, with significantly increased 
protein levels of IFN-γ, MIP-1β, IP-10, RANTES and 
MIG in group 2 mice. MIP-1β and RANTES are members 
of the CC chemokine family, and are homologous to their 
human CCL4 and CCL5 counterparts, respectively. Both 
these CC cytokines can bind to CCR5 receptor and act as 
potent chemoattractants. CCL5 is also involved in wound 
healing [27]. Recent studies have showed that RANTES 
is associated with gastric cancer progression, [28, 29] and 
increased expressions of IP-10 and MIG have also been 
implicated in gastric cancer. [30, 31] IP-10 and MIG, 
binding to the same CXCR3 receptor, are IFN-γ related 
chemokines, and they usually increase in parallel during 
inflammation. [32-34] Our prior experiments in p27-
deficient mice support a role for markedly elevated IP-10 
and MIG protein levels in the dysplastic gastric mucosa 
consequent to persistent H. pylori infection. [18] These 
elevated cytokines and chemokines in group 2 mice that 
received p27 deficient bone marrow cells support the 
idea that BMDC are recruited to the gastric mucosa by 
increased production of chemoattractants locally that may 
serve to perpetuate ongoing inflammation. Control and 
group 3 mice that received wild type bone marrow showed 
a similar and relatively low level of IP-10, RANTES and 
MIG, compared with mice in group 2. In contrast to prior 
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experimental bone marrow transplantation in the context 
of H. pylori infection, [8, 9] group 3 mice that were lacking 
p27 in all cells except in their bone marrow displayed a 
high frequency of bone marrow-derived inflammatory 
cells incorporated into their dysplastic glands. However, 
since the gastric cytokine and chemokine profiles of 
these mice were generally similar to that observed in the 
control mice, which suggests that the mechanisms driving 
bone marrow cell recruitment to the gastric mucosa and 
incorporation of BMDC into dysplastic glands must be 
distinct from the CC/IP-10/MIG-associated processes 
underlying the carcinogenesis in group 2 mice. 
A possible limitation of this study as it applies to 
human H. pylori-induced gastric carcinogenesis is the use 
of a single mouse-adapted H. pylori strain, SS1, that is 
known to lose cag pathogenicity island functionality in 
vivo [35] We used SS1 because it is the standard H. pylori 
strain for mouse models [36] and because it is known to 
induce high-grade dysplasia in p27 knock out mice in our 
laboratory. [12] However, we appreciate that additional 
effects related to the translocation of cagA, an important 
virulence factor for human gastric cancer development, 
may also be clinically relevant.
In conclusion, our results demonstrate that 
both bone marrow-derived and gastric epithelial cells 
contribute to the increased gastric cancer susceptibility 
of p27-deficient H. pylori-infected mice. Based on the 
results from three experimental groups in the present 
study, we conclude that both BMDC and gastric epithelial 
cells are involved in the development of gastric neoplasia 
following H. pylori infection, acting in concert but through 
two distinct pathways. Clinical and translational studies to 
address the relevance of these findings to human gastric 
carcinogenesis should now be considered. 
MATERIALS AND METHODS
Mice, bone marrow transplantation and H. pylori 
infection
Male and female homozygous p27kip1-deficient mice 
were bred in our laboratory from six to eight week-old 
heterozygous p27-deficient founders purchased from The 
Jackson Laboratory (Bar Harbor, ME, USA) as described 
previously. [18] Male C57BL/6-Tg (CAG-EGFP) 131 
Osb/LeySopJ mice (Stock number: 006567) were used as 
bone marrow donors in group one and group 3; female 
C57BL/6 wild type mice were used as recipients in group 
one and group 2. All mice were housed in micro-isolator 
cages under positive air pressure and fed autoclaved 
laboratory chow and water ad libitum throughout. The 
protocol was approved by Rhode Island Hospital’s Animal 
Care and Use Committee. 
At 6 weeks of age, recipient mice were sub-lethally 
exposed to two doses of 450 centigray (cGy) on the same 
day, two hours apart, using a Gammacell® 40 Exactor 
Irradiator (Best Theratronics, Ottawa, Ontario K2K 0E4, 
Canada) and reconstituted with 3 x106 bone marrow (BM) 
cells from GFP transgenic or p27-deficient mice by lateral 
tail vein injection as previously described. [8]
Four weeks after bone marrow transplantation, after 
allowing the recipient mice to recover from irradiation, all 
mice were gavaged with H. pylori Sydney Strain (SS1) of 
approximately 109 bacterial colony forming units (CFU) 
in (200 μl) volume on three occasions over five days as 
described previously. [18] 
All mice were euthanized and their stomachs were 
removed 52 weeks after H. pylori infection, or sooner 
if their condition met Rhode Island Hospital’s Animal 
Care and Use Committee criteria for signs of distress. 
Stomachs were opened along the greater curvature and 
cut into several linear strips for DNA isolation, protein 
extraction and histologic analysis. Mouse serum samples 
were collected for anti-H. pylori IgG detection. H. pylori 
infection status was determined by a combination of 
positive findings on polymerase chain reaction (PCR) of 
DNA isolated from mouse gastric tissue, and anti-H. pylori 
IgG ELISA, as described previously. [37] Only infected 
mice were included in the final analyses.
Y-chromosome detection by fluorescence in 
situ hybridization (FISH), immunofluorescent 
histochemical staining, and image quantification
Y-chromosomes from male donor mice in 
group 2 were detected by performing Fluorescence in 
situ hybridization (FISH). Cyanine (Cy™3) labeled 
Y-chromosome was detected by following the kit’s two-
day protocol (Cambio Ltd, Cambridge, UK). In brief, 
slides were immersed in pre-warmed denaturation buffer 
(70% formamide in 2x saline sodium citrate buffer, 
Invitrogen, Carlsbad, CA, USA) for 2-5 minutes at 65 
°C and the probe was denatured at 65 °C for 10 minutes. 
A mixture of probe (2 μl) and hybridization buffer (8 μl) 
were carefully added to the tissue on each slide. Then the 
slides were placed in a sealed humidified chamber, and 
hybridized at 37 °C overnight. After washing, the tissue 
section was mounted with Vectashield anti-fade mounting 
medium with 4’, 6-diamidino-2-phenylindole (DAPI) to 
counterstain nuclei (Vector Laboratories, Burlingame, 
CA).
Y-chromosome detection by FISH and anti-E-
cadherin immunofluorescence staining was also performed 
on frozen tissue sections of group 1 and 2 mice. The 
mouse Y-chromosome probe used for this experiment 
was labeled with Green 5-Fluorescein dUTP (Empire 
Genomics, Buffalo, NY, USA). Hybridization was carried 
out according to the manufacture’s protocol. Anti-GFP 
and anti-E-cadherin immunofluorescence staining were 
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performed on paraffin-embedded tissue sections after 
antigen retrieval and permeabilization of cell membranes. 
Polyclonal chicken anti-mouse GFP antibody was applied 
at a dilution of 1:200 (Invitrogen Corporation, Carlsbad, 
CA, USA), and monoclonal anti-E-cadherin antibody was 
used at 1:400 (Cell Signaling Technology, Danvers, MA, 
USA). The slides were incubated overnight at 4°C. FITC-
conjugated donkey anti-chicken and Cy™3-conjugated 
donkey anti-rabbit secondary antibodies (Jackson 
Immunoresearch Laboratories Inc., West Grove, PA, 
USA) were applied at 1:400 dilutions for 1 hour at room 
temperature. All slides were mounted with Vectashield 
anti-fade mounting medium with DAPI (Vector 
Laboratories, Burlingame, CA, USA). Images were 
obtained with either a Nikon C1si confocal microscope 
or a Zeiss LSM 710 confocal laser-scanning microscope. 
Identification of Y-chromosome positive cells was based 
on the presence of bright green spots inside DAPI-stained 
blue nuclei. Positive GFP cells were detected as bright 
green staining localized in the cytoplasm.
To quantify the number of Y-chromosome positive 
BMDCs that were incorporated into gastric glands, we 
counted such cells in tissue sections from 3 representative 
mice in each group. Five 8-bit grayscale consecutive high 
power fields per slide were acquired with a Nikon E800 
microscope (Nikon Inc. Mellville, NY, USA) using a 40x 
Plan Apo objective. Quantitative data were expressed 
as the mean of donor-derived cells incorporated into 
the gastric glands ± SEM per high power field for each 
experimental group. 
Histologic evaluation
Each mouse stomach was opened along the greater 
curvature and quickly cut into linear strips. Longitudinal 
gastric strips (including two from the lesser curvature) 
were fixed in 10% neutral-buffered formalin, embedded 
in paraffin, and stained with H&E. Gastric mucosal 
lesions in each mouse were evaluated by a veterinary 
pathologist who was blinded to the experimental details 
using the scoring criteria (0 - 4.0) described previously. 
[11] As mucous metaplasia and hyalinosis may develop 
spontaneously in mice, [6] these sub-scores were excluded 
from the calculation of the histological activity index 
(HAI).
Proinflammatory cytokines and chemokines 
measurement 
We evaluated a panel of three proinflammatory 
cytokines and three chemokines at the protein level by 
a customized multiplex magnetic beads array (EMD 
Millipore, Billerica, MA, USA). The panel comprised 
interferon-gamma (IFN-γ), tumor necrosis factor-
alpha (TNF-α), interleukin-1 beta (IL-1β), monocyte 
chemoattractant protein-1 (MCP-1), macrophage 
inflammatory protein 1-alpha (MIP-1α) and macrophage 
inflammatory protein 1-beta (MIP-1β), interferon gamma-
induced protein 10 (IP-10) regulated upon activation, 
normal T cells-expressed and secreted chemokine 
(RANTES), and Monokine induced by gamma interferon 
(MIG). For these analyses a strip of stomach tissue 
from each mouse was homogenized and total protein 
concentration was measured by BCA protein assay 
kit (Pierce Biotechnology, Rockford, IL). Aliquots of 
the protein samples were then applied to a customized 
multiplex magnetic bead array (EMD Millipore, Billerica, 
MA, USA) according to the manufacturer’s instructions. 
Data were normalized to total protein concentration in 
each sample and expressed as mean ± SEM pg/mg protein.
Statistics
All statistical analysis was performed using 
Graphpad Prism 5.0 software (San Diego, CA) with a 
P level < 0.05 considered as statistically significant. 
Histopathological scores were compared by Kruskal-
Wallis one-way analysis of variance (ANOVA) followed 
by Dunn’s multiple comparison tests. Y-chromosome 
positive and GFP positive donor-derived cells were 
compared by student’s t-test. Cytokine and chemokine 
expression were compared with ANOVA followed by 
Bonferroni’s multiple comparison method. All analyses 
were confined to those mice that were confirmed to be 
successfully infected by H. pylori.
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